Authorized company
BIOMERIEUX S.A.
BIOMERIEUX S.A.
Colombia INVIMA·86 registered devices·Jun 22, 2022 – Apr 08, 2034
86
Total devices
5
Risk classes
2022
Earliest
2034
Latest
Recent registrations
Latest 20 INVIMA device registrations
VIDAS C. DIFFICILE TOXIN A & B
VIDAS C. DIFFICILE TOXIN A & B
036fe8a14cedfb901f4a31526be7dc9c
IIApr 08, 2034
VIDAS 3 - ANALIZADOR DE INMUNOENSAYO VIDAS 3
LIVES 3 - LIVES 3 IMMUNOASSAY ANALYZER
0812309589d19397ce55f1fa8a97d632
IIaMar 20, 2034
VITEK MS CHCA MATRIX
VITEK MS CHCA MATRIX
bf56f3503633041f436b81bab6964d3d
IOct 17, 2033
1. AGAR GARDNERELLA
1. AGAR GARDNERELLA
be00d524013cb3d5d653e5afc2ca01c6
IOct 02, 2033
AGAR CHROMID CARBA (CARB)
AGAR CHROMID CARBA (CARB)
d3815b95f74bc5f17b935f26f69e102d
IDec 05, 2032
SALINE SOLUTION
SALINE SOLUTION
af2a399d8245ec5e39f78650d9d58671
Apr 21, 2031
ARGENE® SARS-COV-2 R-GENE®
ARGENE® SARS-COV-2 R-GENE®
ce2415ceda5c9944b4a714aa86137d2b
Apr 06, 2030
ETEST FOSFOMYCIN
ETEST FOSFOMYCIN
ac2e9e868dd17e59444015c7ab1a92a2
IIAug 01, 2029
ETEST ITRACONAZOLE
ETEST ITRACONAZOLE
f1730efd5184251e9dbf8c9d5266072c
IIAug 01, 2029
VIDAS PTH (1-84)
VIDAS PTH (1-84)
22cf6cb758ceda27108e4c444ef20d32
IIJun 12, 2029
PREVICOLOR GRAM FUSCHIN SOLUTION RA-4
PREVICOLOR GRAM FUSCHIN SOLUTION RA-4
87187067642694027291642e13312282
IMay 02, 2029
PREVICOLOR GRAM CRYSTAL VIOLET SOLUTION RC
PREVICOLOR GRAM CRYSTAL VIOLET SOLUTION RC
3aecb5f13dff3ad66577dc7ab1ae1d65
IMay 02, 2029
PREVICOLOR GRAM ACETONE SAFRANIN SOLUTION RA-1
PREVICOLOR GRAM ACETONE SAFRANIN SOLUTION RA-1
d4a0eb9c22a2115bb77491f6dc0a6642
IMay 02, 2029
PREVICOLOR GRAM IODINESOLUTION RB
PREVICOLOR GRAM IODINESOLUTION RB
15ca396f5552ae6543404c18ff334914
IMay 02, 2029
PREVICOLOR GRAM ACETONE FUSCHIN SOLUTION RA-3
PREVICOLOR GRAM ACETONE FUSCHIN SOLUTION RA-3
a42e783c116b496ffad71c5c5d9eabbd
IMay 02, 2029
PREVICOLOR GRAM SAFRANIN SOLUTION RA-2
PREVICOLOR GRAM SAFRANIN SOLUTION RA-2
a50b19997a0194ab9c7e404ceff83c82
IMay 02, 2029
CEFOTAXIME/CEFOTAXIME+CLAVUNALIC ACID (4 UG/ML)
CEFOTAXIME/CEFOTAXIME+CLAVUNALIC ACID (4 UG/ML)
d97333e2360ebbd971d1dd310cd53ff3
IIFeb 19, 2029
CEFTRIAXONE
CEFTRIAXONE
66d763b592c02abae0d127f642c1e43b
IIFeb 19, 2029
CIPROFLOXACIN
CIPROFLOXACIN
54339988a21457fb20c6418d8b575d41
IIFeb 19, 2029
COLISTIN
COLISTIN
5c79d71737fad8c361f652a11f481d4a
IIFeb 19, 2029
Risk class distribution
Devices by risk class
II
55
64.0% of total
III
14
16.3% of total
I
13
15.1% of total
Unspecified
2
2.3% of total
IIa
2
2.3% of total
About this profile
Explore comprehensive authorized company profile for BIOMERIEUX S.A. through Pure Global AI's free Colombia medical device database. This company manufactures 86 medical devices registered with INVIMA across 5 risk classes. Their registration history spans from Jun 22, 2022 to Apr 08, 2034.
This page provides detailed insights including recent registrations, risk class distribution (III: 14, Unspecified: 2, I: 13, and more), and complete regulatory information from the official Colombia INVIMA medical device database with bilingual Spanish/English support. Pure Global AI offers free access to Colombia's complete medical device registry.